Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $17
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $15 to $17.
Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $15 to $17.